64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
for Prostatic Neoplasms, Castration-Resistant
7 locations incl. Stanford
Sponsor: Clarity Pharmaceuticals Ltd
Sex: Male·Age: 18+
Code: NCT04868604·Phase 1, Phase 2·Recruiting